公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2023 | HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy | Yu, Helena A; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; CHIH-HSIN YANG ; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin; Bironzo, Paolo; Kim, Dong-Wan; Johnson, Melissa L; Wu, Yi-Long; John, Thomas; Kao, Steven; Kozuki, Toshiyuki; Massarelli, Erminia; Patel, Jyoti; Smit, Egbert; Reckamp, Karen L; Dong, Qian; Shrestha, Pomy; Fan, Pang-Dian; Patel, Parul; Sporchia, Andrea; Sternberg, David W; Sellami, Dalila; Jänne, Pasi A | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 14 | 5 | |
2023 | HERTHENA-Lung01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated metastatic EGFR-mutated NSCLC | Yu, Helena A; CHIH-HSIN YANG ; Hayashi, Hidetoshi; Goto, Yasushi; Felip, Enriqueta; Reck, Martin; Vigliotti, Michele; Dong, Qian; Cantero, Frédérique; Fan, Pang-Dian; Kanai, Masayuki; Sternberg, David W; Jänne, Pasi A | Future oncology (London, England) | 5 | 2 | |
2024 | RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants | Nishino, Kazumi; JIN-YUAN SHIH ; Nakagawa, Kazuhiko; Reck, Martin; Garon, Edward B; Carlsen, Michelle; Matsui, Tomoko; Visseren-Grul, Carla; Nadal, Ernest | JTO clinical and research reports | | | |
2023 | TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC | Levy, Benjamin P; Felip, Enriqueta; Reck, Martin; CHIH-HSIN YANG ; Cappuzzo, Federico; Yoneshima, Yasuto; Zhou, Caicun; Rawat, Siddhartha; Xie, Jingdong; Basak, Priyanka; Xu, Lu; Sands, Jacob | Future oncology (London, England) | 5 | 1 | |